Dashboard
With ROE of 12.8, it has a Very Expensive valuation with a 12.7 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -4.06%, its profits have risen by 15.1% ; the PEG ratio of the company is 6.6
Stock DNA
Other Chemical products
INR 49,839 Cr (Mid Cap)
99.00
22
0.21%
-0.01
12.84%
12.43
Total Returns (Price + Dividend) 
Latest dividend: 4.5 per share ex-dividend date: Aug-07-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Linde India Technical Momentum Shifts Amid Mixed Market Signals
Linde India’s recent technical indicators reveal a shift in price momentum, reflecting a more cautious market stance amid mixed signals from key momentum and volume metrics. The stock’s performance contrasts with broader market trends, highlighting nuanced investor sentiment within the Other Chemical products sector.
Read More
Linde India Technical Momentum Shifts Amid Mixed Market Signals
Linde India’s recent technical indicators reveal a nuanced shift in price momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. While the stock’s current price hovers near ₹5,911, its technical landscape suggests cautious navigation for investors amid mixed momentum cues.
Read More
Linde India Technical Momentum Shifts Amid Mixed Market Signals
Linde India’s recent technical indicators reveal a shift in price momentum, reflecting a more cautious market stance despite the company’s long-term performance outpacing broader benchmarks. The stock’s current trading dynamics and technical signals suggest a nuanced outlook for investors navigating the Other Chemical products sector.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
10-Dec-2025 | Source : BSEPlease find enclosed our letter no. Sect/79 dated 10 December 2025 in connection with the Companys announcement under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. You are requested to please take the above on record.
Rumour verification - Regulation 30(11)
08-Dec-2025 | Source : BSEPlease find enclosed our letter no. Sect/78 dated 8 December 2025 with regard to announcement under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. You are requested to please take the above on record.
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
05-Dec-2025 | Source : BSEPlease find enclosed our letter no. Sect/77 dated 5 December 2025 with regard to intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. You are requested to please take the above on record.
Corporate Actions 
No Upcoming Board Meetings
Linde India Ltd. has declared 45% dividend, ex-date: 07 Aug 25
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 27 Schemes (6.29%)
Held by 118 FIIs (2.35%)
The Boc Group Ltd., U.k. (75.0%)
Nippon Life India Trustee Ltd. Through Its Various Funds (2.86%)
12.59%
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is 12.80% vs -3.51% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is 59.53% vs -9.48% in Jun 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -5.62% vs -10.10% in Sep 2024
Growth in half year ended Sep 2025 is 26.39% vs 5.51% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'24
YoY Growth in nine months ended Dec 2024 is -11.46% vs 18.27% in Dec 2023
YoY Growth in nine months ended Dec 2024 is 2.36% vs -0.04% in Dec 2023
Annual Results Snapshot (Consolidated) - Mar'25
Not Applicable: The company has declared_date for only one period
Not Applicable: The company has declared_date for only one period






